SCHEMBL6490940

SCHEMBL6490940

CONC(=O)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13527466 0.78 MGAM (0.50)
SCHEMBL26658157 0.78
SCHEMBL10499955 0.77 RECQL (0.45)
SCHEMBL14091415 0.76 ALDH1A1 (0.38)
SCHEMBL1563023 0.74
SCHEMBL25059 0.74
SCHEMBL7377078 0.74
SCHEMBL4486784 0.74
SCHEMBL4869475 0.72
SCHEMBL14639212 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6864268-B2 β3 adrenergic receptor agonists PFIZER INC. (US) 2005-03-08 US disclosed
EP-1485379-A1 BETA 3-ADRENERGIC RECEPTOR AGONISTS Pfizer Products Inc. (US) 2004-12-15 EP disclosed
US-20030212063-A1 beta3 adrenergic receptor agonists PFIZER INC. 2003-11-13 US disclosed
WO-2003072572-A1 BETA3-ADRENERGIC RECEPTOR AGONISTS PFIZER PRODUCTS INC. (US) 2003-09-04 WO disclosed